Anixa Biosciences is trading 7.17% down now at $3.35 in after-hours trading after closing at $3.60 on August 26, 2026, with no confirmed company-specific catalyst identified.
- No confirmed August 26 company-specific announcement or late-breaking catalyst was identified; the latest company release concerns a September 9–11 healthcare conference presentation.
- Broader markets finished higher, so the decline does not clearly track overall market direction.
- Trading volume and after-hours activity were unavailable.